Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?
The DOI matches its Crossref record, with a small difference in title or year; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Depression is a recurrent illness in which afflicted individuals have an increased risk for recurrence as a function of a greater number of previous episodes. Consequently, prevention of future episodes is central to improving the prognosis. The current recommendation is to use antidepressants over prolonged periods of time to prevent further episodes of depression. However, the database for this practice is limited and can be interpreted in multiple ways. Review of the relevant literature was performed. MEDLINE and PubMed databases were searched from inception to 5 September 2011 for randomized, placebo-controlled trials of at least 18 months duration. After treatment of an acute depressive episode, antidepressants clearly prevent relapse back into the same depressive episode. This is demonstrated by an adequate number of randomized, blinded, placebo-controlled, 1-year continuation trials. The ability of antidepressants to prevent recurrence of future episodes is less clear. Randomized, blinded, placebo-controlled trials of 18 months or longer are infrequent - 18 studies were identified. While nearly all show that antidepressant continuation is superior to placebo in preventing resurgence of depressive symptoms, nearly all of the difference occurs in the first 6 months after randomization. This pattern strongly suggests that the apparent superiority of antidepressants may be due to (i) their ability to prevent recurrence, (ii) antidepressant withdrawal (characterized by depr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research suggests this could pertain to most relapses (El-Mallakh 2012; Greenhouse 1991; Hengartner 2020; Recalt 2019; Rosenbaum 1988).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as El-Mallakh 2012
In the citing paper
“Patients discontinue for a variety of reasons including side effects; and there are indications that tachyphylaxis (Rothschild et al. 2009) and even oppositional tolerance may occur (Andrews et al. 2011; El-Mallakh & Briscoe, 2012).”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as El-Mallakh & Briscoe, 2012
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Distributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., Warshaw, M., & Maser, J. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1000 · Cited by 897
Rush, A. J. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.11.1905 · Cited by 870
Multiple recurrences of major depressive disorder
Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., Coryell, W., Warshaw, M., Turvey, C., Maser, J. D., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.229 · Cited by 835
Research works printed but not linked: 6
- 2000, Am J Psychiatry, 157, 1
- Brunoni, 2009, Ther Clin Risk Manag, 5, 897
- Robinson, 1991, Psychopharmacol Bull, 27, 31
- Gilaberte, 2001, J Clin Psychopharmacol, 21, 417, 10.1097/00004714-200108000-00009 · DOI · Paper page
- Schatzberg, 2006, J Clin Psychiatry, 67, 27
- Delgado, 2006, J Clin Psychiatry, 67, 22
Cited by
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Coventry, P. A., Hudson, J. L., Kontopantelis, E., Archer, J., Richards, D. A., Gilbody, S., Lovell, K., Dickens, C., Gask, L., Waheed, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108114 · Cited by 221
“Recurrence of symptoms is also common, but patients who continue treatment with antidepressants reduce the risk of recurrence by 70% compared with those who discontinue treatment [47], although it is not clear whether reduction in relapse represents true long term efficacy or avoidance of relapse precipitated by antid…”
BackgroundGuidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
Braun, C., Bschor, T., Franklin, J., & Baethge, C. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442293 · Cited by 103
Predicting relapse after antidepressant withdrawal – a systematic review
Berwian, I. M., Walter, H., Seifritz, E., & Huys, Q. J. M. (2017) · Psychological Medicine · doi:10.1017/s0033291716002580 · Cited by 93
“Patients discontinue for a variety of reasons including side effects; and there are indications that tachyphylaxis (Rothschild et al. 2009) and even oppositional tolerance may occur (Andrews et al. 2011; El-Mallakh & Briscoe, 2012).”
Background
Metadata
- Authors
- El-Mallakh, R. S., & Briscoe, B.
- Affiliations
- University of Louisville (US)
- Venue
- CNS Drugs
- Published
- 2012-02
- Volume
- 26
- Issue
- 2
- Pages
- 97-109
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W88939737
- Semantic Scholar
- 6fec670b39401a8b8921c21514df5795688ee707
- Cited by
- 36
- References
- 67
- Citations by year
- 2025: 1 · 2024: 5 · 2021: 4 · 2020: 3 · 2019: 4 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 2
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressants, long-term antidepressant use, depression, relapse prevention, recurrence prevention, antidepressant discontinuation, depressive symptoms
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Humans, Statistics as Topic, Time Factors, Randomized Controlled Trials as Topic, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted? https://app.cochat.ai/papers/10.2165/11599450-000000000-00000
- The paper
- El-Mallakh, R. S., & Briscoe, B. (2012). Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted? CNS Drugs. https://doi.org/10.2165/11599450-000000000-00000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.